Synthetic biology uses natural molecules and assembles them into a system that acts unnaturally. The ability to control the transfer of molecules through cellular membranes is an important function in synthetic biology. However, building self-contained modules with designer properties, and then integrating them into host cells without adverse effects, is an enormous challenge. Now, a study from researchers at Harvard University introduces a novel mechanical method for controlling release of molecules inside cells at a nanoscale level. The team state they have developed retractable nanoneedles using ‘R bodies’, that can extend to puncture cellular membranes and release molecules on command. The study is published in the journal American Chemical Society Synthetic Biology.
Previous studies show that R bodies respond to pH levels to extend from a tightly bound coil to a long, thin structure akin to a nanoscale needle or javelin. In nature, the bacteria containing R bodies are shed by a killer strain of single-celled organisms called paramecia. When a paramecium of a different strain ingests these shed bacteria containing R bodies, a difference in pH level between the two strains causes the R bodies to extend and puncture the bacteria’s cell walls, releasing toxins that kill the host paramecium. The current study shows that R bodies are biological machines that can be used to break through cell membranes which don’t consume molecular fuel and are extremely robust.
The current study shows that R bodies present a physical rather than genetic strategy for manipulating cells. Results show that at high pH levels, R bodies resemble a coil of ribbon and at lower pH levels, they undergo a conformational change converting them into pointy hollow tubes capable of puncturing through membranes, breaking that barrier and releasing any cargo contained inside. Data findings show that by modifying the pH level that triggers this response, R bodies become a tunable platform for controlling release of toxins or therapies.
The lab state that what’s also unique about R bodies is their reversibility and although they extend in low pH, they retract back into a tight coil when the pH level rises. They go on to add that since bacterial and eukaryotic cells all contain compartmentalized membranes, a reversible system for breaking barriers establishes a mechanical strategy for precisely controlling cells. The findings show that R bodies are capable of acting as synthetic pH-dependent pistons that can puncture E. coli membranes to release the trapped content.
The team surmise that R bodies now represent a whole new way of controlling delivery of beneficial molecules such as biologic therapies, pharmaceutical drugs or other payloads to specific cells. They go on to add that this is a great example of how the global medical community can mine living systems for unique biological elements and adapt them to develop programmable technologies for high value applications using synthetic biology. For the future, the researchers state this advance could potentially lead to a range of applications in biotechnology and medicine such as creation of new programmable biomaterials, drug delivery, and ecosystem management.
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.